https://www.ema.europa.eu/medicines/human/EPAR/imnovid-previously-pomalidomide-celgene 2013 false United Kingdom English French pomalidomide PVD Regimen pomalidomide pomalidomide orphan drug production drug approval europe treatment outcome immunologic factors immunologic factors administration, oral multiple myeloma adult drug therapy, combination summary of product characteristics package leaflet drug evaluation syndication feed angiogenesis inhibitors angiogenesis inhibitors risk management drug interactions pregnancy breast feeding fertility teratogens survival analysis clinical trials, phase iii as topic drug evaluation, preclinical thalidomide